Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000
The in vitro antimicrobial susceptibility of the respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to commonly tested and prescribed agents was investigated during 1999-2000 and compared with results obtained during a previous 1997-1998 study. Of 448 i...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2001-01-01
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600002 |
id |
doaj-3e0598acbd3f43848c5599032edafc76 |
---|---|
record_format |
Article |
spelling |
doaj-3e0598acbd3f43848c5599032edafc762020-11-25T03:47:26ZengElsevierBrazilian Journal of Infectious Diseases1413-86701678-43912001-01-0156294304Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000Critchley Ian A.Blosser Renée S.Karlowsky James A.Yamakita JuriBarth AlfonsoSader Helio S.Mendes CaioTeixeira LuciaRossi FlaviaDias Cicero A. C.Jones Mark E.Thornsberry ClydeSahm Daniel F.The in vitro antimicrobial susceptibility of the respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to commonly tested and prescribed agents was investigated during 1999-2000 and compared with results obtained during a previous 1997-1998 study. Of 448 isolates of S. pneumoniae collected and tested in 1999-2000, 77.2% were susceptible, 19.9% were intermediate, and 2.9% were resistant to penicillin, demonstrating that there were no major changes in susceptibility to penicillin from 1997-1998 (77.1% susceptible, 18.7% intermediate, 4.2% resistant). All S. pneumoniae isolates from 1999-2000 were susceptible to levofloxacin and vancomycin, and >90% were susceptible to the beta-lactams (amoxicillin-clavulanate, ceftriaxone, and cefuroxime) and macrolides (azithromycin and clarithromycin), showing that susceptibility to these agents also remained unchanged since 1997-1998. The most notable increase in resistance between the two studies was demonstrated by trimethoprim-sulfamethoxazole, which increased from 23.4% to 38.6%. Penicillin resistance correlated with resistance to beta-lactams, macrolides, and trimethoprim-sulfamethoxazole in both studies. In H. influenzae, the prevalence of beta-lactamase-producing isolates remained unchanged (10.6% in 1999-2000; 11.0% in 1997-1998). All H. influenzae isolates were susceptible to levofloxacin, ceftriaxone, cefuroxime, and azithromycin, and showed no change between the two studies. Trimethoprim-sulfamethoxazole resistance was present in 40.1% of isolates in 1999-2000, and in 45.2% in 1997-1998. In M. catarrhalis, the prevalence of beta-lactamase-producing isolates was unchanged (97.9% in 1999-2000; 98.0% in 1997-1998). The most active agents against M. catarrhalis were azithromycin (MIC90, <0.03 mug/ml) and levofloxacin (MIC90, 0.03 mug/ml). Overall, these results suggest that, in Brazil, between 1999-2000 and 1997-1998, there have been no significant changes in the susceptibility of respiratory pathogens to any of the commonly tested and prescribed agents with the exception of trimethoprim-sulfamethoxazole for S. pneumoniae.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600002Streptococcus pneumoniaeantimicrobial resistancesurveillance studyrespiratory pathogen |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Critchley Ian A. Blosser Renée S. Karlowsky James A. Yamakita Juri Barth Alfonso Sader Helio S. Mendes Caio Teixeira Lucia Rossi Flavia Dias Cicero A. C. Jones Mark E. Thornsberry Clyde Sahm Daniel F. |
spellingShingle |
Critchley Ian A. Blosser Renée S. Karlowsky James A. Yamakita Juri Barth Alfonso Sader Helio S. Mendes Caio Teixeira Lucia Rossi Flavia Dias Cicero A. C. Jones Mark E. Thornsberry Clyde Sahm Daniel F. Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 Brazilian Journal of Infectious Diseases Streptococcus pneumoniae antimicrobial resistance surveillance study respiratory pathogen |
author_facet |
Critchley Ian A. Blosser Renée S. Karlowsky James A. Yamakita Juri Barth Alfonso Sader Helio S. Mendes Caio Teixeira Lucia Rossi Flavia Dias Cicero A. C. Jones Mark E. Thornsberry Clyde Sahm Daniel F. |
author_sort |
Critchley Ian A. |
title |
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 |
title_short |
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 |
title_full |
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 |
title_fullStr |
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 |
title_full_unstemmed |
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000 |
title_sort |
antimicrobial resistance in respiratory pathogens isolated in brazil during 1999-2000 |
publisher |
Elsevier |
series |
Brazilian Journal of Infectious Diseases |
issn |
1413-8670 1678-4391 |
publishDate |
2001-01-01 |
description |
The in vitro antimicrobial susceptibility of the respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to commonly tested and prescribed agents was investigated during 1999-2000 and compared with results obtained during a previous 1997-1998 study. Of 448 isolates of S. pneumoniae collected and tested in 1999-2000, 77.2% were susceptible, 19.9% were intermediate, and 2.9% were resistant to penicillin, demonstrating that there were no major changes in susceptibility to penicillin from 1997-1998 (77.1% susceptible, 18.7% intermediate, 4.2% resistant). All S. pneumoniae isolates from 1999-2000 were susceptible to levofloxacin and vancomycin, and >90% were susceptible to the beta-lactams (amoxicillin-clavulanate, ceftriaxone, and cefuroxime) and macrolides (azithromycin and clarithromycin), showing that susceptibility to these agents also remained unchanged since 1997-1998. The most notable increase in resistance between the two studies was demonstrated by trimethoprim-sulfamethoxazole, which increased from 23.4% to 38.6%. Penicillin resistance correlated with resistance to beta-lactams, macrolides, and trimethoprim-sulfamethoxazole in both studies. In H. influenzae, the prevalence of beta-lactamase-producing isolates remained unchanged (10.6% in 1999-2000; 11.0% in 1997-1998). All H. influenzae isolates were susceptible to levofloxacin, ceftriaxone, cefuroxime, and azithromycin, and showed no change between the two studies. Trimethoprim-sulfamethoxazole resistance was present in 40.1% of isolates in 1999-2000, and in 45.2% in 1997-1998. In M. catarrhalis, the prevalence of beta-lactamase-producing isolates was unchanged (97.9% in 1999-2000; 98.0% in 1997-1998). The most active agents against M. catarrhalis were azithromycin (MIC90, <0.03 mug/ml) and levofloxacin (MIC90, 0.03 mug/ml). Overall, these results suggest that, in Brazil, between 1999-2000 and 1997-1998, there have been no significant changes in the susceptibility of respiratory pathogens to any of the commonly tested and prescribed agents with the exception of trimethoprim-sulfamethoxazole for S. pneumoniae. |
topic |
Streptococcus pneumoniae antimicrobial resistance surveillance study respiratory pathogen |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600002 |
work_keys_str_mv |
AT critchleyiana antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT blosserrenees antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT karlowskyjamesa antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT yamakitajuri antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT barthalfonso antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT saderhelios antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT mendescaio antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT teixeiralucia antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT rossiflavia antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT diasciceroac antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT jonesmarke antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT thornsberryclyde antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 AT sahmdanielf antimicrobialresistanceinrespiratorypathogensisolatedinbrazilduring19992000 |
_version_ |
1724501798106955776 |